Monitoring drug therapy in the intensive care unit

Critical Care Nursing Quarterly

Volumn 22, Issue 4, 2000, Pages 14-22

  Cuddy, Paul G ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytochrome P 450; Drug interactions; Drug monitoring; Drug therapy; Intensive care units; Medication errors; Pharmacokinetics

Indexed keywords

AMINOGLYCOSIDE; AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; CIMETIDINE; CISAPRIDE; CYCLOSPORIN; CYTOCHROME P450; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ETHYLENE GLYCOL; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; LIDOCAINE; LITHIUM; LOW DENSITY LIPOPROTEIN; MACROLIDE; METHANOL; METOCLOPRAMIDE; PARACETAMOL; PHENYTOIN; PROTEINASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; THEOPHYLLINE; UNINDEXED DRUG; VANCOMYCIN; WARFARIN;

ANGIONEUROTIC EDEMA; BLEEDING; COUGHING; DEEP VEIN THROMBOSIS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MONITORING; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; NEUTROPENIA; PARTIAL THROMBOPLASTIN TIME; REVIEW;

EID: 0033960222     PISSN: 08879303     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002727-200002000-00003     Document Type: Review

References (12)

1. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
2. Aronoff GR, Berns JS, Brier ME, et al., eds. Drug Prescribing in Renal Failure: Dosing Guidelines for Adults. 4th ed. Philadelphia: American College of Physicians; 1999.
3. Bass NB, Williams RL. Guide to drug dosage in hepatic disease. Clin Pharmacokinet. 1988;15:396-420.
4. Hansten PD, Horn JR. Drug Interactions and Updates. Philadelphia: Lea & Febiger; Drug Interactions Newsletter. Vancouver, WA: Applied Therapeutics; 1990.
5. Hansten PD, Horn JR. Drug Interactions and Updates. Philadelphia: Lea & Febiger; Drug Interactions Newsletter. Vancouver, WA: Applied Therapeutics; 1990.
6. Rizack MA. The Medical Letter Handbook of Adverse Drug Interactions. New Rochelle, NY: The Medical Letter; 1994.
7. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. JAMA. 1995;274:29-34.
8. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. JAMA. 1998;279:1200-1205.
9. Evans RS, Pestotnik SL, Classen DC, Horn SD, Bass SB, Burke JP. Preventing adverse drug events in hospitalized patients. Ann Pharmacother. 1994;28:523-527.
10. Leape LL, Bates DW, Cullen DJ, et al. Systems analysis of adverse drug events. JAMA. 1995;274:35-43.
11. Schumacher GE. Therapeutic Drug Monitoring. Stamford, CT: Appleton & Lange; 1995.
12. Evans WE. General principles of applied pharmacokinetics. In: Evans WE, Schentag JJ, Jusko WJ, eds. Applied Pharmacokinetics. Philadelphia: Lippincott Williams & Wilkins; 1986.